Elevated levels of circulating IGFBP2 were found to be associated with PAH severity and mortality.
Pulmonary vein sign was found to be easy to detect and to have higher sensitivity and specificity in chronic thromboembolic pulmonary hypertension compared with acute pulmonary embolism.
Patients who are hospitalized with COVID-19 and have an elevated vs normal troponin levels were found to be at higher risk for death.
Pulmonary arterial compliance was found to be strongly associated with all-cause mortality and clinical worsening in patients with systemic lupus erythematosus-associated pulmonary arterial hypertension.
The surgical management of patients with massive pulmonary embolism and high-risk submassive PE was found to be safe and highly effective for achieving right ventricular recovery.
Pulmonary artery denervation in patients with residual chronic thromboembolic pulmonary hypertension after pulmonary endarterectomy was associated with improved hemodynamics and clinical and functional status compared with medical therapy.
Continuous positive airway pressure was effective for preventing cardiovascular disease in patients with severe obstructive sleep apnea.
